Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Cancers

Explore clinical trials studying Advanced Solid Cancers. Study availability and eligibility vary by location and protocol.

14 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Cancers trial results

Recruiting

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

NCT07186842

Conditions
Adnexal Diseases, Advanced Solid Cancers, Bile Duct Diseases, +29 more
Locations
  • SCRI at HCA Health One Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Monash Health Clayton, Australia
View all 16 locations
View Trial Details
Recruiting

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

NCT07238075

Conditions
Advanced Malignancy, Advanced Solid Cancers, Chemically-Induced Disorders, +3 more
Locations
  • Macquarie University Sydney, New South Wales, Australia
  • Blacktown Hospital Sydney, New South Wales, Australia
  • Sunshine Coast University Private Hospital Birtinya, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor

NCT07612891

Conditions
Adnexal Diseases, Advanced Solid Cancers, Breast Cancer (Locally Advanced or Metastatic), +28 more
Locations
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
View Trial Details
Completed

AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy

NCT02694822

Conditions
Advanced Solid Cancers, Advanced Solid Cancers Refractory to PD-1 and PD-L1 Therapies
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
View Trial Details
Completed

An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers

NCT03956680

Conditions
Advanced Solid Cancers
Locations
  • Local Institution - 0003 Chicago, Illinois, United States
  • Local Institution - 0005 St Louis, Missouri, United States
  • Local Institution - 0006 Pittsburgh, Pennsylvania, United States
  • Local Institution - 0002 Nashville, Tennessee, United States
View Trial Details

Related conditions